tomeko

Autosomal dominant dopa-responsive dystonia

Just diagnosed with Autosomal dominant dopa-responsive dystonia?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Autosomal dominant dopa-responsive dystonia, look for clinical trials, and connect with others living with it — all in one place.

Open the full Autosomal dominant dopa-responsive dystonia hub →

Overview

Autosomal dominant dopa-responsive dystonia is a rare condition. Also known as Autosomal dominant Segawa syndrome, DYT5a, GTPCH1-deficient DRD, GTPCH1-deficient dopa-responsive dystonia, HPD with marked diurnal fluctuation, Hereditary progressive dystonia with marked diurnal fluctuation. Tomeko brings together the specialists, research, clinical trials, treatments and community for Autosomal dominant dopa-responsive dystonia so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:98808 · OMIM 128230, 619911 · ICD-10 G24.1 · GARD 0027165

Find care for Autosomal dominant dopa-responsive dystonia

Authoritative references for Autosomal dominant dopa-responsive dystonia

Common questions

I was just diagnosed with Autosomal dominant dopa-responsive dystonia — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Autosomal dominant dopa-responsive dystonia, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Autosomal dominant dopa-responsive dystonia?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Autosomal dominant dopa-responsive dystonia, filtered to your area.

Are there clinical trials for Autosomal dominant dopa-responsive dystonia?

Tomeko shows live, recruiting studies for Autosomal dominant dopa-responsive dystonia from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com